Legend Biotech Corp (LEGN) Operating income 2023–2025
Legend Biotech Corp (LEGN) annual operating income history from SEC filings — each fiscal year as reported.
-$136.5MFY2025 · since FY2023: -$528.1M → -$136.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$136.5M | +55.9% |
| FY2024 | -$309.5M | +41.4% |
| FY2023 | -$528.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LEGN financial trends
LEGN RevenueLEGN Net incomeLEGN Net marginLEGN Gross profitLEGN Gross marginLEGN Operating marginLEGN Operating cash flowLEGN Free cash flowLEGN Capital expendituresLEGN Return on equityLEGN Stock buybacksLEGN Dividends paidLEGN Total assetsLEGN Total liabilitiesLEGN Shareholders’ equityLEGN overview →